{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:32:43Z","timestamp":1792477963183,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006513","name":"Duke Clinical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ahj.2017.08.001","type":"journal-article","created":{"date-parts":[[2017,8,5]],"date-time":"2017-08-05T06:16:42Z","timestamp":1501913802000},"page":"35-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach"],"prefix":"10.1016","volume":"193","author":[{"given":"Gheorghe","family":"Doros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kandzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J.","family":"Koolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald E.","family":"Cutlip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2017.08.001_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1191\/1740774505cn100oa","article-title":"Introduction to Bayesian methods III: use and interpretation of Bayesian tools in design and analysis","volume":"2","author":"Berry","year":"2005","journal-title":"Clin Trials"},{"key":"10.1016\/j.ahj.2017.08.001_bb0010","series-title":"Guidance for the use of Bayesian statistics in medical device clinical trials","author":"Food and Drug Administration","year":"2010"},{"key":"10.1016\/j.ahj.2017.08.001_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/2229-516X.96789","article-title":"Use of Bayesian statistics in drug development: advantages and challenges","volume":"2","author":"Gupta","year":"2012","journal-title":"Int J Appl Basic Med Res"},{"key":"10.1016\/j.ahj.2017.08.001_bb0020","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa067722","article-title":"Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden","volume":"356","author":"Lagerqvist","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.08.001_bb0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2217\/fca.11.1","article-title":"How safe and how good are drug-eluting stents?","volume":"7","author":"Kabir","year":"2011","journal-title":"Future Cardiol"},{"key":"10.1016\/j.ahj.2017.08.001_bb0030","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents","volume":"48","author":"Pfisterer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.08.001_bb0035","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1056\/NEJMp068304","article-title":"Stent thrombosis redux\u2014the FDA perspective","volume":"356","author":"Farb","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.08.001_bb0040","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1016\/S0140-6736(11)61706-6","article-title":"Polymer drug-eluting stents: is the future biodegradable?","volume":"378","author":"Waksman","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.08.001_bb0045","first-page":"789","article-title":"Randomized comparison of the Nobori biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries","volume":"80","author":"Kadota","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2017.08.001_bb0050","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jacc.2011.06.027","article-title":"Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial","volume":"58","author":"Byrne","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.08.001_bb0055","first-page":"811","volume":"124","author":"Xu","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ahj.2017.08.001_bb0060","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1093\/eurheartj\/ehu210","volume":"35","author":"Saito","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2017.08.001_bb0065","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(12)61962-X","article-title":"Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial","volume":"381","author":"Christiansen","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.08.001_bb0070","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0140-6736(14)61038-2","article-title":"Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial","volume":"384","author":"Pilgrim","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.08.001_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002372","article-title":"Efficacy and safety of a novel bioabsorbable polymer-coated, everolimus-eluting coronary stent: the EVOLVE II Randomized Trial","volume":"8","author":"Kereiakes","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2017.08.001_bb0080","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.115.003610","article-title":"Randomized comparison of a biodegradable polymer ultrathin strut sirolimus-eluting stent with a biodegradable polymer biolimus-eluting stent in patients treated with percutaneous coronary intervention: the SORT OUT VII Trial","volume":"9","author":"Jensen","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2017.08.001_bb0085","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.4244\/EIJY15M03_08","article-title":"Real-world experience with a novel biodegradable polymer sirolimus-eluting stent: twelve-month results of the BIOFLOW-III registry","volume":"11","author":"Waltenberger","year":"2016","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2017.08.001_bb0090","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4244\/EIJV5I7A146","article-title":"Myocardial infarction adjudication in contemporary all-comer stent trials: balancing sensitivity and specificity. Addendum to the historical MI definitions used in stent studies","volume":"5","author":"Vranckx","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2017.08.001_bb0095","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.08.001_bb0100","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.08.001_bb0105","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jacc.2005.11.077","article-title":"Two-year outcomes after sirolimus-eluting stent implantation: results from the Sirolimus-Eluting Stent in de Novo Native Coronary Lesions (SIRIUS) trial","volume":"47","author":"Weisz","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.08.001_bb0110","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(03)14462-5","article-title":"Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)","volume":"362","author":"Schofer","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2017.08.001_bb0115","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jacc.2004.01.024","article-title":"The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS)","volume":"43","author":"Schampaert","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2017.08.001_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.CIR.0000047700.58683.A1","article-title":"TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions","volume":"107","author":"Grube","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.08.001_bb0125","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/01.CIR.0000086926.62288.A6","article-title":"Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions","volume":"108","author":"Colombo","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.08.001_bb0130","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/01.CIR.0000127110.49192.72","article-title":"One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial","volume":"109","author":"Stone","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.08.001_bb0135","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.294.10.1215","article-title":"Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial","volume":"294","author":"Stone","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2017.08.001_bb0140","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1161\/CIRCULATIONAHA.105.552190","article-title":"Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice","volume":"112","author":"Dawkins","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.08.001_bb0145","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.105.591206","article-title":"Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial","volume":"114","author":"Fajadet","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.08.001_bb0150","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/sim.1425","article-title":"Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics","volume":"22","author":"D'Agostino","year":"2003","journal-title":"Stat Med"},{"key":"10.1016\/j.ahj.2017.08.001_bb0155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/01.CIR.102.1.118","article-title":"A classification of unstable angina revisited","volume":"102","author":"Hamm","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.08.001_bb0160","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1700456","article-title":"Surgical or transcatheter aortic-valve replacement in intermediate-risk patients","volume":"376","author":"Reardon","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2017.08.001_bb0165","doi-asserted-by":"crossref","first-page":"e001441","DOI":"10.1161\/CIRCINTERVENTIONS.114.001441","article-title":"Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial","volume":"8","author":"Windecker","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ahj.2017.08.001_bb0170","first-page":"286","article-title":"A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial","volume":"2","author":"Serruys","year":"2006","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ahj.2017.08.001_bb0175","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.108.803528","volume":"119","author":"Stone","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2017.08.001_bb0180","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317302211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870317302211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:59:18Z","timestamp":1757570358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870317302211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":36,"alternative-id":["S0002870317302211"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2017.08.001","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale of a novel study design for the BIOFLOW V study, a prospective, randomized multicenter study to assess the safety and efficacy of the Orsiro sirolimus-eluting coronary stent system using a Bayesian approach","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2017.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}